Skip to main navigation

Sorrento Therapeutics

Search

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Aug 26, 2022
Document Date
Aug 26, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Sorrento Therapeutics
Issuer
SORRENTO THERAPEUTICS, INC.
Filer
JI HENRY

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Tools

  • Print

    Print

  • Email Alerts

    Email Alerts

  • RSS Feeds

    RSS Feeds

  • Email Page

    Email Page

© 2023 Sorrento Therapeutics. All Rights Reserved.

Footer

    Terms of Use Privacy Policy DMCA Trademarks Linking Policy
logo

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact